{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:11:09Z","timestamp":1787587869536,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.neuroscience.2025.01.040","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T19:46:39Z","timestamp":1737229599000},"page":"202-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts"],"prefix":"10.1016","volume":"568","author":[{"given":"Hayder M.","family":"Al-Kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9859-6466","authenticated-orcid":false,"given":"Salwa H.","family":"Zekry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarak","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.01.040_b0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.21608\/ejh.2018.4314.1013","article-title":"Efficacy of cerebrolysin on dentate gyrus of hippocampus after experimentally induced acute ischemic stroke in adult albino rats (Histological, immunohistochemical and biochemical study)","volume":"42","author":"Abdel-aziz","year":"2019","journal-title":"Egypt. J. Histol."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113257","article-title":"Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia","volume":"328","author":"Abrahamson","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.720715","article-title":"Vascular Dementia and Underlying Sex Differences","volume":"13","author":"Akhter","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/ijpvm.IJPVM_5_19","article-title":"Vinpocetine Improves Oxidative Stress and Pro-Inflammatory Mediators in Acute Kidney Injury","volume":"10","author":"Al-Kuraishy","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11064-022-03817-4","article-title":"A Potential Link Between Visceral Obesity and Risk of Alzheimer's Disease","volume":"48","author":"Al-Kuraishy","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0030","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jnr.25171","article-title":"SARS-COV-2 infection and Parkinson's disease: Possible links and perspectives","volume":"101","author":"Al-Kuraishy","year":"2023","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/japtr.JAPTR_18_20","article-title":"Metformin and\/or vildagliptin mitigate type II diabetes mellitus induced-oxidative stress: The intriguing effect","volume":"11","author":"Al-Kuraishy","year":"2020","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0040","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/syn.21588","article-title":"Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice","volume":"66","author":"Alc\u00e1ntara-Gonz\u00e1lez","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0045","article-title":"Cerebrolysin improves symptoms and delays progression in patients with Alzheimer's disease and vascular dementia","volume":"48 Suppl A:25\u201341","author":"Allegri","year":"2012","journal-title":"Drugs Today (barc)"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113225","article-title":"Pentoxifylline and berberine mitigate diclofenac-induced acute nephrotoxicity in male rats via modulation of inflammation and oxidative stress","volume":"152","author":"Alorabi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/ijnp\/pyaa046","article-title":"Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer's Disease","volume":"23","author":"Alvarez","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.psychres.2018.10.008","article-title":"Prevention of memory impairment induced by post-traumatic stress disorder by cerebrolysin","volume":"270","author":"Alzoubi","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.112823","article-title":"Cerebrolysin prevents sleep deprivation induced memory impairment and oxidative stress","volume":"217","author":"Alzoubi","year":"2020","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0070","first-page":"2299","article-title":"Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke","volume":"10","author":"Amiri-Nikpour","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0075","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1007\/s12031-022-02078-8","article-title":"Cerebrolysin Alleviating Effect on Glutamate-Mediated Neuroinflammation Via Glutamate Transporters and Oxidative Stress","volume":"72","author":"Avci","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jns.2009.02.041","article-title":"The blood brain barrier in vascular dementia, a morphological and morphometric study","volume":"283","author":"Baloyannis","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-022-01087-8","article-title":"Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal","volume":"31","author":"Batiha","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0090","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/00207454.2020.1817009","article-title":"Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced vascular dementia","volume":"132","author":"Bhatia","year":"2022","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0095","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JAD-2011-110566","article-title":"Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease","volume":"27","author":"Bjerke","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0100","first-page":"2581","article-title":"Progression of Cognitive Deficit in Older People with Mild Cognitive Impairment Treated with Cerebrolysin","volume":"6","author":"Boksha","year":"2014","journal-title":"Health (n y)"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0105","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.3892\/mmr.2016.4891","article-title":"Effect of exercise-induced neurogenesis on cognitive function deficit in a rat model of vascular dementia","volume":"13","author":"Choi","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0110","doi-asserted-by":"crossref","unstructured":"Cui S, Chen N, Yang M, Guo J, Zhou M, Zhu C, He L (2019), Cerebrolysin for vascular dementia. Cochrane Database Syst Rev 2019.","DOI":"10.1002\/14651858.CD008900.pub3"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0115","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1460-9568.2011.07616.x","article-title":"Neurogenesis in humans","volume":"33","author":"Curtis","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0120","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11055-008-9014-5","article-title":"Effects of cerebrolysin on moderate cognitive impairments in cerebral vascular insufficiency (a clinical-electrophysiological study)","volume":"38","author":"Damulin","year":"2008","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0125","doi-asserted-by":"crossref","unstructured":"Dey D, Suresh V, Shamim MA, Javed B, Dhakal B, Verma A, Khan M, Singha N, et al. (2024) Efficacy of Pharmacotherapies in Improving Cognitive Function in Vascular Dementia: A Network Meta-analysis of Randomized Controlled Trials (P11-9.006).","DOI":"10.1212\/WNL.0000000000206157"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/STROKEAHA.112.670844","article-title":"Prevalence of poststroke cognitive impairment: South London Stroke Register 1995-2010","volume":"44","author":"Douiri","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0135","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.neurobiolaging.2010.01.007","article-title":"Increased neural progenitors in vascular dementia","volume":"32","author":"Ekonomou","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0140","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":"Inflammatory proteins in plasma and the risk of dementia: the rotterdam study","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0145","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s10072-021-05089-2","article-title":"Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes","volume":"42","author":"Fiani","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116662","article-title":"Mixed dementia: Neglected clinical entity or nosographic artifice?","volume":"410","author":"Fierini","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0155","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/FBP.0000000000000530","article-title":"Cerebrolysin enhances the expression of the synaptogenic protein LRRTM4 in the hippocampus and improves learning and memory in senescent rats","volume":"31","author":"Flores-P\u00e1ez","year":"2020","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1219847","article-title":"Defective hippocampal neurogenesis underlies cognitive impairment by carotid stenosis-induced cerebral hypoperfusion in mice","volume":"17","author":"Fraga","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pbb.2014.09.005","article-title":"Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats","volume":"126","author":"Fu","year":"2014","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116071","article-title":"Peptides Derived from Growth Factors to Treat Alzheimer's Disease","volume":"22","author":"Gascon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0175","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000377672","article-title":"Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials","volume":"39","author":"Gauthier","year":"2015","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0180","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/med.21722","article-title":"Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use","volume":"41","author":"Gavrilova","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0185","first-page":"153","article-title":"Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial","volume":"10","author":"Gharagozli","year":"2017","journal-title":"J. Med. Life"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15407\/fz68.04.020","article-title":"Cerebrolysin administration counteracts elevated oxidative stress in blood of patients with Parkinson\u2019s disease","volume":"68","author":"Gonchar","year":"2022","journal-title":"Fiziolohichny\u012d Zhurnal"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0195","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3389\/fphar.2019.01245","article-title":"Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB\/PGC-1\u03b1 Pathway","volume":"10","author":"Guan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0200","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.01.012","article-title":"Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial","volume":"20","author":"Guekht","year":"2011","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0205","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1124\/dmd.123.001443","article-title":"Identification and Validation of Active Ingredient in Cerebrotein Hydrolysate-I Based on Pharmacokinetic and Pharmacodynamic Studies","volume":"51","author":"Guo","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0210","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3233\/JAD-220012","article-title":"Prevalence of Dementia and Main Subtypes in Mexico: The Study on Aging and Dementia in Mexico (SADEM)","volume":"89","author":"Juarez-Cedillo","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0215","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/syn.20950","article-title":"The chronic administration of cerebrolysin induces plastic changes in the prefrontal cortex and dentate gyrus in aged mice","volume":"65","author":"Ju\u00e1rez","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0220","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202300439","article-title":"Treatment with Cerebrolysin Prolongs Lifespan in a Mouse Model of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy","volume":"8","author":"Kastberger","year":"2024","journal-title":"Advanced Biology"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/biom14070773","article-title":"Tanaka K-i, Kato-Negishi M, Zinc, Copper, and Calcium: A Triangle in the Synapse for the Pathogenesis of Vascular-Type Senile Dementia","author":"Kawahara","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0230","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood-brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12206638","article-title":"Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis","volume":"12","author":"Kojder","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0240","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00406-007-0732-4","article-title":"Changes in neurogenesis in dementia and Alzheimer mouse models: are they functionally relevant?","volume":"257","author":"Kuhn","year":"2007","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254493","article-title":"Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats","volume":"16","author":"Kurkin","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0250","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jalz.2018.06.3061","article-title":"Stroke and dementia risk: A systematic review and meta-analysis","volume":"14","author":"Ku\u017ama","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.727590","article-title":"Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors","volume":"13","author":"Lecordier","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0260","article-title":"Inflammation and Rho-Associated Protein Kinase-Induced Brain Changes in Vascular Dementia","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/cns.13572","article-title":"Pathological changes in neurovascular units: Lessons from cases of vascular dementia","volume":"27","author":"Li","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0270","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2017.04.022","article-title":"Cerebrolysin alleviates cognitive deficits induced by chronic cerebral hypoperfusion by increasing the levels of plasticity-related proteins and decreasing the levels of apoptosis-related proteins in the rat hippocampus","volume":"651","author":"Liu","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0275","doi-asserted-by":"crossref","DOI":"10.1590\/acb370605","article-title":"Cerebrolysin alleviates early brain injury after traumatic brain injury by inhibiting neuroinflammation and apoptosis via TLR signaling pathway","volume":"37","author":"Lu","year":"2022","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512080","article-title":"The Effect of Cerebrolysin in an Animal Model of Forebrain Ischemic-Reperfusion Injury: New Insights into the Activation of the Keap1\/Nrf2\/Antioxidant Signaling Pathway","volume":"24","author":"Marghani","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0285","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/ciia.2006.1.3.229","article-title":"Vascular dementia: prevention and treatment","volume":"1","author":"McVeigh","year":"2006","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0290","first-page":"11","article-title":"Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage","author":"Morega","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0295","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jns.2009.02.042","article-title":"Neuroprotection and neuroplasticity \u2013 A short consensus of the concepts: Clinical utility of neurotrophic factor therapy (cerebrolysin) in VaD \u2013 Data from a new pilot clinical study","volume":"283","author":"Muresanu","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0300","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2007.10.016","article-title":"A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration","volume":"267","author":"Muresanu","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0305","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jns.2010.08.040","article-title":"Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study","volume":"299","author":"Muresanu","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144869","article-title":"Regulation of Adult Neurogenesis in Mammalian Brain","volume":"21","author":"Niklison-Chirou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0315","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/j.eurpsy.2017.01.2073","article-title":"The Effectiveness and Long-term Prognosis of the Intravenous Course of Cerebrolysin in Patients with the Amnestic MCI","volume":"41","author":"Ponomareva","year":"2017","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0320","article-title":"Vascular dementia subtypes, pathophysiology, genetics, neuroimaging, biomarkers, and treatment updates along with its association with Alzheimer's dementia and diabetes mellitus","volume":"69","author":"Prajjwal","year":"2023","journal-title":"Dis. Mon."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0325","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.7150\/thno.68304","article-title":"Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment","volume":"12","author":"Rajeev","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0330","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/med.21960","article-title":"Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin","volume":"43","author":"Rejdak","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0335","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13311-021-01170-y","article-title":"Vascular Cognitive Impairment (VCI)","volume":"19","author":"Rundek","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0340","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000091434","article-title":"Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study","volume":"21","author":"Sachdev","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0345","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.stem.2023.01.002","article-title":"Adult hippocampal neurogenesis in Alzheimer's disease: A roadmap to clinical relevance","volume":"30","author":"Salta","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0350","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.2009.05329.x","article-title":"Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat","volume":"1199","author":"Sharma","year":"2010","journal-title":"Ann. n. y. Acad. Sci."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0355","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/syn.21912","article-title":"Cerebrolysin improves memory and ameliorates neuronal atrophy in spontaneously hypertensive, aged rats","volume":"70","author":"Solis-Gaspar","year":"2016","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0360","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.25122\/jml-2023-0125","article-title":"A retrospective study of Cerebrolysin in patients with moderate to severe traumatic brain injury: Cognitive and functional outcomes","volume":"16","author":"Soto","year":"2023","journal-title":"J. Med. Life"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0365","doi-asserted-by":"crossref","unstructured":"Strilciuc S, V\u00e9csei L, Boering D, Pra\u017enikar A, Kaut O, Riederer P, Battistin L (2021), Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials. Pharmaceuticals (Basel) 14.","DOI":"10.20944\/preprints202109.0446.v2"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0370","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41440-019-0357-9","article-title":"Roles of vascular risk factors in the pathogenesis of dementia","volume":"43","author":"Takeda","year":"2020","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0375","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12935","article-title":"Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia","volume":"31","author":"Tayler","year":"2021","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0380","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/WNR.0000000000001598","article-title":"Therapeutic effect of Cerebrolysin on reducing impaired cerebral endothelial cell permeability","volume":"32","author":"Teng","year":"2021","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0385","doi-asserted-by":"crossref","unstructured":"Tian Z, Ji X, Liu J (2022), Neuroinflammation in Vascular Cognitive Impairment and Dementia: Current Evidence, Advances, and Prospects. Int J Mol Sci 23.","DOI":"10.3390\/ijms23116224"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0390","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jnr.23142","article-title":"Cerebrolysin modulates pronerve growth factor\/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease","volume":"91","author":"Ubhi","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0395","series-title":"Frontiers in Cell and Developmental Biology 8","article-title":"Improving Cerebrovascular Function to Increase Neuronal Recovery in Neurodegeneration Associated to Cardiovascular Disease","author":"Vanherle","year":"2020"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0400","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10787-021-00806-x","article-title":"Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection","volume":"29","author":"Welcome","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0405","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2147\/NDT.S311760","article-title":"Cerebroprotein Hydrolysate-I Inhibits Hippocampal Neuronal Apoptosis by Activating PI3K\/Akt Signaling Pathway in Vascular Dementia Mice","volume":"17","author":"Wu","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0410","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6693955","article-title":"Exploring the Oxidative Stress Mechanism of Buyang Huanwu Decoction in Intervention of Vascular Dementia Based on Systems Biology Strategy","volume":"2021","author":"Yang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0415","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-024-02043-0","article-title":"Autophagy Regulation Attenuates Neuroinflammation and Cognitive Decline in an Alzheimer's Disease Mouse Model with Chronic Cerebral Hypoperfusion","author":"Yang","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.neuroscience.2025.01.040_b0420","first-page":"11","article-title":"A Study on the Pathogenesis of Vascular Cognitive Impairment and Dementia: The Chronic Cerebral Hypoperfusion Hypothesis","author":"Yu","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0425","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1002\/jnr.22495","article-title":"Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke","volume":"88","author":"Zhang","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0430","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.715443","article-title":"Beneficial Effects on Brain Micro-Environment by Caloric Restriction in Alleviating Neurodegenerative Diseases and Brain Aging","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0435","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3171\/2013.3.JNS122061","article-title":"Improvement in functional recovery with administration of Cerebrolysin after experimental closed head injury","volume":"118","author":"Zhang","year":"2013","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuroscience.2025.01.040_b0440","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1545968318809916","article-title":"Cerebrolysin Reduces Astrogliosis and Axonal Injury and Enhances Neurogenesis in Rats After Closed Head Injury","volume":"33","author":"Zhang","year":"2019","journal-title":"Neurorehabil. Neural Repair"},{"issue":"Cd007026","key":"10.1016\/j.neuroscience.2025.01.040_b0445","article-title":"Cerebrolysin for acute ischaemic stroke","volume":"10","author":"Ziganshina","year":"2023","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:41:24Z","timestamp":1777264884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":89,"alternative-id":["S0306452225000508"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.01.040","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}